In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
The FAMHP launches the Medicinal Product Management database

The FAMHP launches the Medicinal Product Management database

by In2Pharma | Jul 5, 2022 | News

Belgium On 4th of July 2022, the FAMHP launches the Medicinal Product Management database, a new internal database for medicinal products. Due to the launch of the new database, existing databases will temporarily not be updated. As from 22nd June data will be...
Joint headquarters for the FPS Public Health, the NIHDI and the FAMHP

Joint headquarters for the FPS Public Health, the NIHDI and the FAMHP

by In2Pharma | Feb 23, 2021 | News

Belgium The FPS Health, Food Chain Safety and Environment, the National Institute for Sickness and Disability Insurance (NIHDI) and the Federal Agency for Medicines and Health Products (FAMHP) will move to a common building on 1 March 2021. This enables an even...

Practical recommendations for the new verification system against Falsified Medicines

by In2Pharma | Feb 12, 2019 | News

Belgium In light of the Falsified Medicines Directive, that came into effect on 9th February 2019, FAMHP has issued practical guidelines for the handling of complications during the initial phase of the new verification system. FAMHP and BeMVO have worked out an...

Recent Posts

  • MDR/IVDR Implementation – Amendment Transitional Provisions
  • Medical devices – turnover declaration
  • Update instructions for distribution of DHPC in Luxembourg
  • Diploma for the Responsible Person for Information and Publicity (RIP)
  • Update Procedure for MA applications in Luxembourg

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België